Related Experiment Video
Updated: May 31, 2026
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Rituximab in chronic lymphocytic leukemia
Danelle F James1, Thomas J Kipps
1Diversion of Hematology/Oncology, Moores UCSD Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093-0820, USA. dfjames@ucsd.edu
Advances in Therapy
|July 5, 2011
Summary
Rituximab, a CD20-targeted therapy, shows limited activity alone in chronic lymphocytic leukemia (CLL). However, combining rituximab with chemotherapy significantly improves patient survival in CLL treatment.
Area of Science:
- Oncology
- Immunology
- Hematology
Background:
- Rituximab is a chimeric monoclonal antibody targeting CD20 on B lymphocytes.
- Chronic lymphocytic leukemia (CLL) is a B-cell malignancy.
- CD20 expression is a key target in CLL therapy.
Purpose of the Study:
- To review clinical studies on rituximab's efficacy in CLL.
- To evaluate rituximab as a single agent and in combination therapy.
- To assess rituximab's role in improving survival for CLL patients.
Main Methods:
- Review of clinical trial data for rituximab in CLL.
- Analysis of studies combining rituximab with chemotherapy.
- Evaluation of single-agent rituximab activity.
Main Results:
- Rituximab monotherapy has limited clinical activity in CLL.
- Combination therapy with rituximab and chemotherapy improves survival.
- FDA approved rituximab for CLL in combination with fludarabine and cyclophosphamide.
Conclusions:
- Rituximab is effective in CLL when combined with chemotherapy.
- Combination therapy enhances patient outcomes in chronic lymphocytic leukemia.
- Rituximab represents a significant advancement in CLL treatment protocols.
